PaxVax, Inc. – FDA Inspection, May 16, 2018

Record Details

This FDA Inspection record concerns PaxVax, Inc., with an inspection on May 16, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: PaxVax, Inc.
Inspection Date: May 16, 2018
Product Type: Biologics
Office: Center for Biologics Evaluation and Research
People: Laurissa S. Flowers (Issuing Officer)
Michele L. Forster (Investigator)

View Company Profile

ID · b981c1f2-9986-4973-8cd9-f83901b17cb9

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1052793
FDA center: Biologics
Project area: Vaccines and Allergenic Products
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore PaxVax, Inc.

FDA Inspection

PaxVax, Inc.May 16, 2018